‘Indian pharma will have to balance generic drugs with innovation’ & more related News Here
New Delhi: India’s pharmaceutical industry should focus on both generic and innovative products, as well as develop products specifically tailored to the needs of the country’s patients. Pharma leaders said at India Pharma 2026 on Tuesday that domestic companies, especially small to medium-sized companies, can play a stronger role in rare diseases and specific patient…